BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28141845)

  • 1. Prevalence of ESBL-Producing Enterobacteriaceae in Pediatric Bloodstream Infections: A Systematic Review and Meta-Analysis.
    Flokas ME; Karanika S; Alevizakos M; Mylonakis E
    PLoS One; 2017; 12(1):e0171216. PubMed ID: 28141845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bloodstream infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae among patients with malignancy: a systematic review and meta-analysis.
    Alevizakos M; Gaitanidis A; Andreatos N; Arunachalam K; Flokas ME; Mylonakis E
    Int J Antimicrob Agents; 2017 Nov; 50(5):657-663. PubMed ID: 28705665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections: A systematic review and meta-analysis.
    Flokas ME; Detsis M; Alevizakos M; Mylonakis E
    J Infect; 2016 Dec; 73(6):547-557. PubMed ID: 27475789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis.
    Alevizakos M; Karanika S; Detsis M; Mylonakis E
    Int J Antimicrob Agents; 2016 Dec; 48(6):647-654. PubMed ID: 27746102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and Burden of Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in a Pediatric Hospital in Senegal.
    Ndir A; Diop A; Faye PM; Cissé MF; Ndoye B; Astagneau P
    PLoS One; 2016; 11(2):e0143729. PubMed ID: 26867226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and prognostic factors in bloodstream infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae among patients with malignancy: a meta-analysis.
    Jiang AM; Liu N; Zhao R; Zheng HR; Chen X; Fan CX; Zhang R; Zheng XQ; Fu X; Yao Y; Tian T
    Ann Clin Microbiol Antimicrob; 2020 Nov; 19(1):53. PubMed ID: 33228668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-lactam/beta-lactamase inhibitors versus carbapenem for bloodstream infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: systematic review and meta-analysis.
    Sfeir MM; Askin G; Christos P
    Int J Antimicrob Agents; 2018 Nov; 52(5):554-570. PubMed ID: 30081138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae in pregnant/post-partum women: Systematic review and meta-analysis.
    Jalilian N; Kooshkiforooshani M; Ahmadi S; Nankali A
    J Glob Antimicrob Resist; 2019 Dec; 19():338-347. PubMed ID: 31212106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary tract infections caused by ESBL-producing Enterobacteriaceae in renal transplant recipients: A systematic review and meta-analysis.
    Alevizakos M; Nasioudis D; Mylonakis E
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28803446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended-spectrum β-lactamase-producing Enterobacteriaceae colonisation in long-term care facilities: a systematic review and meta-analysis.
    Flokas ME; Alevizakos M; Shehadeh F; Andreatos N; Mylonakis E
    Int J Antimicrob Agents; 2017 Nov; 50(5):649-656. PubMed ID: 28782707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of bloodstream infection caused by extended-spectrum β-lactamase-producing enterobacteriaceae determined using multistate modeling at a Swiss University Hospital and a nationwide predictive model.
    Stewardson A; Fankhauser C; De Angelis G; Rohner P; Safran E; Schrenzel J; Pittet D; Harbarth S
    Infect Control Hosp Epidemiol; 2013 Feb; 34(2):133-43. PubMed ID: 23295559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.
    Lübbert C; Straube L; Stein C; Makarewicz O; Schubert S; Mössner J; Pletz MW; Rodloff AC
    Int J Med Microbiol; 2015 Jan; 305(1):148-56. PubMed ID: 25547265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?
    Barbier F; Pommier C; Essaied W; Garrouste-Orgeas M; Schwebel C; Ruckly S; Dumenil AS; Lemiale V; Mourvillier B; Clec'h C; Darmon M; Laurent V; Marcotte G; Lucet JC; Souweine B; Zahar JR; Timsit JF;
    J Antimicrob Chemother; 2016 Apr; 71(4):1088-97. PubMed ID: 26755492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal Colonization With Extended-spectrum Beta-lactamase-Producing Enterobacteriaceae and Risk Factors Among Healthy Individuals: A Systematic Review and Metaanalysis.
    Karanika S; Karantanos T; Arvanitis M; Grigoras C; Mylonakis E
    Clin Infect Dis; 2016 Aug; 63(3):310-8. PubMed ID: 27143671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of extended spectrum beta-lactamase-producing enterobacteriaceae in neonates: A community based cohort in Madagascar.
    Herindrainy P; Rabenandrasana MAN; Andrianirina ZZ; Rakotoarimanana FMJ; Padget M; de Lauzanne A; Ndir A; Kermorvant-Duchemin E; Garin B; Piola P; Collard JM; Guillemot D; Huynh BT; Delarocque-Astagneau E;
    PLoS One; 2018; 13(3):e0193325. PubMed ID: 29494706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International travel is a risk factor for extended-spectrum β-lactamase-producing Enterobacteriaceae acquisition in children: A case-case-control study in an urban U.S. hospital.
    Strysko JP; Mony V; Cleveland J; Siddiqui H; Homel P; Gagliardo C
    Travel Med Infect Dis; 2016; 14(6):568-571. PubMed ID: 27890813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended spectrum beta-lactamase producing Enterobacteriaceae causing bloodstream infections in rural Ghana, 2007-2012.
    Eibach D; Belmar Campos C; Krumkamp R; Al-Emran HM; Dekker D; Boahen KG; Kreuels B; Adu-Sarkodie Y; Aepfelbacher M; Park SE; Panzner U; Marks F; May J
    Int J Med Microbiol; 2016 Jun; 306(4):249-54. PubMed ID: 27222489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis.
    Shamsrizi P; Gladstone BP; Carrara E; Luise D; Cona A; Bovo C; Tacconelli E
    BMJ Open; 2020 Jan; 10(1):e030266. PubMed ID: 31964661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae.
    Zahar JR; Lesprit P; Ruckly S; Eden A; Hikombo H; Bernard L; Harbarth S; Timsit JF; Brun-Buisson C;
    Int J Antimicrob Agents; 2017 Jan; 49(1):67-73. PubMed ID: 27890442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Risk Score for Prediction of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates.
    Augustine MR; Testerman TL; Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
    Infect Control Hosp Epidemiol; 2017 Mar; 38(3):266-272. PubMed ID: 27989244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.